Pillstats
Rx only · Tablet, Film Coated · Oral

Diflunisal

Brands: Dolobid · Diflunisal

4 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US5 NDCs
4 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC
RxCUI (US)
US makers4 labelers
Packages9
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 6 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.345$0.690$1.03$1.38Dec 2025Mar 2026Jun 2026
$1.061
Latest avg · Jun 17, 2026
-10%
Since Dec 17, 2025
4
Active US suppliers
67%
Top-2 supplier share*

Who makes it4 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Teva Pharmaceuticals USA, Inc.unknown3SUPPLYING
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.unknown3SUPPLYING
INA PHARMACEUTICS INC.unknown2SUPPLYING
Chartwell RX, LLCunknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.